Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-02-01 @ 9:30 AM
Study NCT ID:
NCT00312650
Status:
TERMINATED
Last Update Posted:
2015-01-12
First Post:
2006-04-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Doxil and Gemcitabine in Recurrent Ovarian Cancer
Sponsor:
Women and Infants Hospital of Rhode Island
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
05-0120
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |